REG - Bridgepoint Group - Statement regarding Press Speculation

BridgepointAnnouncement

28/11/2022 18:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221128:nRSb8420Ha&default-theme=true

RNS Number : 8420H  Bridgepoint Group plc  28 November 2022

28 November 2022

Bridgepoint Group plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD
CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH
JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

Statement regarding press speculation

Bridgepoint Group plc ("Bridgepoint" or the "Company") notes the recent media
speculation regarding possible M&A.  The Company confirms it is
evaluating a number of potential strategic opportunities in line with its
stated strategy and as confirmed in its recent trading update.  All such
discussions, including those held with Energy Capital Partners, remain at an
early stage and there is no certainty that any transaction will result.

Further announcements will be made if appropriate.

 

-ENDS-

 

Enquiries

Bridgepoint

 

 Analysts and investors

 Adam Key

 adam.key@bridgepoint.eu (mailto:adam.key@bridgepoint.eu)

 +44 7833 748010

 Media

 Christian Jones / James Murray

 Christian.jones@bridgepoint.eu (mailto:Christian.jones@bridgepoint.eu)

 James.murray@bridgepoint.eu (mailto:James.murray@bridgepoint.eu)

 +44 20 7034 3500

 

Finsbury Glover Hering (Public Relations Adviser to Bridgepoint)

 

 Charles O'Brien

  +44 20 7251 3801 / +44 7825 043656

 Anjali Unnikrishnan

  +44 20 7251 3801 / +44 7826 534233

 Bridgepoint@Finsbury.com (mailto:Burgundy@Finsbury.com)

 

 

The person responsible for this announcement on behalf of the Company is
Rachel Thompson, Group General Counsel of Bridgepoint.

This announcement has been prepared for the purpose of complying with the
applicable law and regulation of the United Kingdom and information disclosed
may not be the same as that which would have been disclosed if this
announcement had been prepared in accordance with the laws and regulations of
jurisdictions outside the United Kingdom.

This announcement may include statements that are, or may be deemed to be,
forward-looking statements. These forward-looking statements may be identified
by the use of forward-looking terminology, including the terms "believes",
"estimates", "envisages", "plans", "projects", "anticipates", "targets",
"aims", "expects", "intends", "may", "will" or "should" or, in each case,
their negative or other variations or comparable terminology, or by
discussions of strategy, plans, objectives, goals, future events or
intentions. These forward looking statements include all matters that are not
historical facts and involve predictions. Forward-looking statements may and
often do differ materially from actual results or outcomes. Any
forward-looking statements reflect the Company's current view with respect to
future events and are subject to risks relating to future events and other
uncertainties and assumptions. Forward-looking statements speak only as of the
date they are made and cannot be relied upon. Save as required by law or
regulation, the Company disclaims any obligation or undertaking to release
publicly any updates or revisions to any forward-looking statements in this
announcement that may occur due to any change in its expectations or to
reflect events or circumstances after the date of this announcement.

None of the contents of the Company's website, nor of any other website, is
incorporated in, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  SPCFLFEDLALTFIF